A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients

American Journal of Geriatric Psychiatry

Volumn 9, Issue 4, 2001, Pages 406-414

  Mulsant, B H ^a   Pollock, B G ^a   Nebes, R ^a   Miller, M D ^a   Sweet, R A ^a   Stack, J ^a   Houck, P R ^a   Bensasi, S ^a   Mazumdar, S ^a   Reynolds III, C F ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NORTRIPTYLINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ELDERLY CARE; FEMALE; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANCHOLIA; OUTPATIENT CARE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 84903185400     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200111000-00009     Document Type: Article

References (45)

1. Antidepressant prescribing practices of outpatient psychiatrists
2. Use of antidepressants among elderly subjects: Trends and contributing factors
3. Update on the treatment of late-life depression
4. Selective serotonin-reuptake inhibitors vs. tricyclic antidepressants: A metaanalysis of efficacy and tolerability
5. Pharmacologic considerations in the treatment of late-life depression
6. Comparative efficacy of selective serotonin-reuptake inhibitors and tricyclics in the treatment of melancholia
7. Two combined, multi-center, double-blind studies of paroxetine and doxepin in geriatric patients with major depression
8. Multicenter double-blind study of paroxetine and amitriptyline in elderly depressed inpatients
9. A double-blind, multicentre study of paroxetine vs. clomipramine in depressed elderly patients
10. A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia
11. A multi-center, blind study to compare the efficacy and tolerability of paroxetine and clomipramine in elderly patients with reactive depression
12. A double-blind, randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: Six-week outcome
13. Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician
14. The use of the Hamilton Rating Scale for Depression in elderly patients with cognitive impairment and physical illness
15. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale (CIRS)
16. The UKU Side Effect Rating Scale
17. Resistance to antidepressant medications and short-term clinical response to ECT
18. Low use of neuroleptic drugs in the pharmacologic treatment of psychotic major depression
19. Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline
20. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression
21. Clinical predictors of response to antidepressants in elderly patients
22. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients
23. Acute efficacy of ECT in the treatment of major depression in the old-old
24. The impact of restrictive entry criteria during the placebo lead-in period
25. Paroxetine binding to the rat norepinephrine transporter in vivo
26. The treatment of severe depression: Is there an efficacy gap between SSRI and TCA antidepressant generations?
27. Danish University Antidepressant Group: Citalopram: Clinical effect profile in comparison to clomipramine: A controlled multi-center study
28. Paroxetine a selective serotonin-reuptake inhibitor showing better tolerance but weaker antidepressant effect than clomipramine in a controlled multicenter study
29. SSRIs vs. tricyclic antidepressants in depressed in-patients: A metaanalysis of efficacy and tolerability
30. Explicit criteria for determining inappropriate medication use in nursing home residents
31. Inappropriate medication prescribing in homebound older adults
32. Inappropriate drug prescribing for the community-dwelling elderly
33. Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease
34. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life
35. Heuristic comparison of sertraline with nortriptyline for the treatment of depression in frail elderly patients
36. Nortriptyline vs. fluoxetine in the treatment of depression and in short-term recovery after stroke: A placebo-controlled, double-blind study
37. A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression
38. Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression
39. A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression
40. New developments in the treatment of late-life depression
41. A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients
42. Medication resistance and clinical response to electroconvulsive therapy
43. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease
44. Paroxetine vs. nortriptyline in the continuation and maintenance treatment of depression in the elderly